• English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016

Thumbnail
View/Open
Article (140.9Kb)
Self archived version
published version
Date
2017
Author
Mathur A
Fernández-Avilés F
Dimmeler S
Hauskeller C
Janssens S
Menasche P
Wojakowski W
Martin JF
Zeiher A
the BAMI Investigators
Unique identifier
10.1093/eurheartj/ehw640
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Mathur A. Fernández-Avilés F. Dimmeler S. Hauskeller C. Janssens S. Menasche P. Wojakowski W. Martin JF. Zeiher A. the BAMI Investigators. (2017). The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.  EUROPEAN HEART JOURNAL, 38 (39) , 2930-2935. 10.1093/eurheartj/ehw640.
Rights
© Authors
Licensed under
CC BY-NC http://creativecommons.org/licenses/by-nc/4.0/
Abstract

In 2006, the Task Force of the European Society of Cardiology published its consensus document on the use of autologous cell therapy for repair of the heart.1 Since then, there have been numerous clinical trials and analyses performed to establish the role of autologous cell therapy in the treatment of both acute and chronic cardiac disease. The majority of these studies have been Phase II clinical trials. Phase III clinical trials of autologous cell therapy have been launched (e.g. BAMI), which marks the successful progression of clinical investigation of autologous cell therapy in heart disease. The Task Force has reviewed its 2006 recommendations and the developments in this area of research and proposes updated recommendations for the future of autologous cell therapy in the heart. This article does not duplicate the many reviews on stem cells and the heart but gives considered recommendations based on the experience from the last 10 years (Table 1).

URI
https://erepo.uef.fi/handle/123456789/5806
Link to the original item
http://dx.doi.org/10.1093/eurheartj/ehw640
Publisher
Oxford University Press (OUP)
Collections
  • Terveystieteiden tiedekunta
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
Send Feedback
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
Send Feedback
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog